Company page

Repligen Corporation

Repligen Corporation (Ticker: RGEN) is a public company based in America, specializing in bioprocessing technologies for the global life sciences industry. With a market capitalization of approximately $7.44 billion, Repligen focuses on providing innovative solutions that enhance the efficiency and effectiveness of biopharmaceutical manufacturing. The company's offerings support the production of biologics, including monoclonal antibodies and gene therapies.